Keryx Biopharmaceuticals Inc fka KERX

[biopa]

Looking for some feedback. In my estimation KERX is in a once in a decade position. Granted they have turned in mediocre sales performance, but nothing that can't be cured with the proper sales/marketing program. They have the best dialysis drug and new FDA approval for IDA.- a market they have not even begun to tap. Even I couldn't mess this opportunity up. If current management can't make it happen - new management or a new owner will. This is the best investment opportunity I have seen in biotech for some time. This price decrease is a buying opportunity not a selling opportunity. Don't let the shorts win. Your opinion / feedback